Gaiane M. Rauch MD, PhD, Presenter: Nothing to Disclose

Leonardo Pimentel Marcal MD, Abstract Co-Author: Nothing to Disclose

Katherine Osusky Castle MD, Abstract Co-Author: Nothing to Disclose

Ann Klopp MD, PhD, Abstract Co-Author: Nothing to Disclose

The purpose of this exhibit is to present a new MRI protocol for imaging of intracavitary brachytherapy probes and its use for radiation treatment planning, review the MRI compatible brachytherapy devices and their acceptable positioning, and discuss structured reporting format of imaging findings.

1. Review a new MRI protocol utilizing T2 3D series for imaging of the brachytherapy device, evaluation of adequate placement of the brachytherapy probe, assessment of residual tumor burden, and its use for radiation therapy planning. 2. Review existing MRI compatible brachytherapy devices for cervical cancer treatment and discuss their application depending on the tumor burden. 3. Discuss appropriate reporting of the imaging findings and propose a structured report format.  

New MRI protocol utilizing T2 3D series for imaging of patients with intracavitary brachytherapy devices decreases imaging time, provides high quality diagnostic images for radiologic interpretation and helps to improve radiation therapy planning.

Rauch, G, Marcal, L, Castle, K, Klopp, A, MRI in Intracavitary Brachytherapy of the Cervical Cancer: What Radiologists Need to Know.  Radiological Society of North America 2013 Scientific Assembly and Annual Meeting, December 1 - December 6, 2013 ,Chicago IL. http://archive.rsna.org/2013/13021387.html